Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Tucson, Ariz. (February 1, 2023) – The PGA TOUR Champions, the Tucson Conquistadores, the First Tee Tucson, and Exact Sciences, the maker of Cologuard®, announced today that the Madison, Wisconsin-based company will now be the presenting sponsor of the Cologuard Classic. The announcement also extends Cologuard’s title sponsorship through the 2027 season. The 2023 Cologuard Classic by Exact Sciences will take place at the Omni Tucson National Resort from February 27th through March 5th and will have a $2.2 million purse, with $330,000 to the winner.Continue reading

AZAdvances Talent Program Internship Opportunities

A component of the  AZAdvances Talent Program, AZAdvances internships are designed to support Arizona students as they explore career paths in health and life sciences.  Internships are created in partnership with AZBio member organizations and are supported though grants and donations to the Opportunity Through Entrepreneurship Foundation’s benefiting the AZAdvances initiative.Continue reading

Arizona’s Opportunity to Drive Health Innovation Forward Faster

In 2022, Arizona established the Arizona Health Innovation Trust Fund as a vehicle to drive the creation of health innovations that can improve quality of life for people of Arizona and increase opportunities for the high quality jobs Arizona Health Innovators create.  The FY2023 appropriation was $100,000 to allow the initial set up of the fund.  In 2023, two bills at the Arizona Legislature (HB2253 and SB1084) propose a $200 million dollar one-time investment into the Arizona Health Innovation Trust Fund.Continue reading

C-Path’s TRxA Announces its First Global Request for Proposals from Academic Investigators Working to Advance Drug Development Projects

Launched in 2022, the Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. TRxA is now accepting applications for its 2023 funding cycle.Continue reading